Genome editing, organoids, gene therapy, in vivo delivery
About
Develops and translates genome editing with human organoids and in vivo models. Focus on base/prime editing, CRISPR functional genomics in stem cells, and AAV/LNP delivery to enable preclinical validation and a path to genetic medicines.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.